Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human IKBKG Antibodies:
anti-Mouse (Murine) IKBKG Antibodies:
anti-Rat (Rattus) IKBKG Antibodies:
Go to our pre-filtered search.
Human Monoclonal IKBKG Primary Antibody for SimWes, WB - ABIN252501
Wunderlich, Luedde, Singer, Schmidt-Supprian, Baumgartl, Schirmacher, Pasparakis, Brüning: Hepatic NF-kappa B essential modulator deficiency prevents obesity-induced insulin resistance but synergizes with high-fat feeding in tumorigenesis. in Proceedings of the National Academy of Sciences of the United States of America 2008
Show all 7 Pubmed References
Human Monoclonal IKBKG Primary Antibody for ICS - ABIN1177069
Carter, Pennington, Ungurait, Ballard: In vivo identification of inducible phosphoacceptors in the IKKgamma/NEMO subunit of human IkappaB kinase. in The Journal of biological chemistry 2003
Show all 6 Pubmed References
Human Monoclonal IKBKG Primary Antibody for FACS, WB - ABIN252492
Harhaj, Sun: IKKgamma serves as a docking subunit of the IkappaB kinase (IKK) and mediates interaction of IKK with the human T-cell leukemia virus Tax protein. in The Journal of biological chemistry 1999
Show all 5 Pubmed References
Human Monoclonal IKBKG Primary Antibody for ELISA - ABIN4324315
Han, Karabiyikoglu, Kelly, Sobel, Yenari: Mild hypothermia inhibits nuclear factor-kappaB translocation in experimental stroke. in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2003
Show all 5 Pubmed References
Human Polyclonal IKBKG Primary Antibody for ICC, ELISA - ABIN1002508
Li, Kang, Friedman, Tarassishin, Ye, Kovalenko, Wallach, Horwitz: Identification of a cell protein (FIP-3) as a modulator of NF-kappaB activity and as a target of an adenovirus inhibitor of tumor necrosis factor alpha-induced apoptosis. in Proceedings of the National Academy of Sciences of the United States of America 1999
Show all 4 Pubmed References
Human Monoclonal IKBKG Primary Antibody for WB - ABIN387828
Mooster, Cancrini, Simonetti, Rossi, Di Matteo, Romiti, Di Cesare, Notarangelo, Geha, McDonald: Immune deficiency caused by impaired expression of nuclear factor-kappaB essential modifier (NEMO) because of a mutation in the 5' untranslated region of the NEMO gene. in The Journal of allergy and clinical immunology 2010
Show all 6 Pubmed References
Human Polyclonal IKBKG Primary Antibody for ELISA, ICC - ABIN4324313
Sadaka, Marloie-Provost, Soumelis, Benaroch: Developmental regulation of MHC II expression and transport in human plasmacytoid-derived dendritic cells. in Blood 2009
Computational analysis identified two miR (show MLXIP Antibodies)-107 binding sites in the 3'UTR (show UTS2R Antibodies) of IKBKG suggesting that IKBKG expression is regulated by miR (show MLXIP Antibodies)-107.
Human IKKgamma does not interact with mammalian Atg8-family proteins.
Data suggest the angiopoietin-like 8 (ANGPTL8)/p62 (show GTF2H1 Antibodies)-IKKgamma axis as a negative feedback loop that regulates NF-kappaB (show NFKB1 Antibodies) activation, and extends the role of selective autophagy in fine-tuned inflammatory responses.
this study demonstrates immunodeficiency in two female patients with Incontinentia Pigmenti with heterozygous NEMO mutation diagnosed by lipopolysaccharide unresponsiveness
GSK-3beta is critically important for ordered NF-kappaB (show NFKB1 Antibodies) signalling through modulation of NEMO phosphorylation.
HOTAIR operates the action of IKKalpha (show CHUK Antibodies), IKKbeta (show IKBKB Antibodies), IKKgamma in liver cancer stem cells
the present study found that loss of the NEMO-SHARPIN (show SHARPIN Antibodies) interaction impaired recruitment of truncated NEMO forms into punctuate structures that are transiently formed on cell stimulation and thus led to a defect in linear ubiquitination
NEMO was critically involved in the cGAS-STING pathway.
Results show that NEMO's expression is regulated by ASAP3 (show ASAP3 Antibodies) which it interacts directly with it reducing its poly-ubiquitinylation.
E+P treatment of breast cancer cells increased ER binding to the NEMO promoter, thereby increasing NEMO expression.
NEMO deficiency hampered activation of IKK (show CHUK Antibodies) complex in osteoclast precursors, causing arrest of osteoclastogenesis and apoptosis. Interestingly, inhibiting apoptosis by genetic ablation of TNFr1 (show TNFRSF1A Antibodies) significantly increased cell survival, but failed to rescue osteoclastogenesis or reverse osteopetrosis (show CSF1 Antibodies).
This study provides evidence for a protective function of canonical IKK (show CHUK Antibodies)/NF-kappaB (show NFKB1 Antibodies) signalling in the arenchymal compartment during pancreatitis. In the absence of the regulatory IKK (show CHUK Antibodies) subunit NEMO, a combination of a fibrogenic gene signature, enhanced acinar-ductal metaplasia and a lack of regeneration contribute to the exacerbation of pancreatitis.
robust caspase (show CASP3 Antibodies) activation in NEMO-deficient cells is concomitant with RIPK3 (show RIPK3 Antibodies) recruitment to the apoptosis-mediating complex.
lymphocyte-specific deletion of IKK2 (show IKBKB Antibodies) or NEMO aggravated kidney injury after ischemia-reperfusion injury, and, in both conditions, the percentage of Th17 cells was increased.
Whereas Parkin (show PARK2 Antibodies) has been reported to positively regulate the expression of OPA1 (show MED12 Antibodies) through NEMO, herein we found that PARK2 (show PARK2 Antibodies) overexpression did not modify the expression of OPA1 (show MED12 Antibodies).
prevents colon inflammation by NF-kappaB (show NFKB1 Antibodies)-independent functions
Thyrocyte-specific NEMO knock-out mice gradually develop hypothyroidism after birth, which leads to reduced body weight and shortened life span.
SENP1 (show SENP1 Antibodies) deletion in adipocytes causes Type 1 diabetes mellitus via enhanced SUMOylation of NEMO, leading to increased NF-kappaB (show NFKB1 Antibodies) activity, cytokine production and pancreatic inflammation.
Drosophila Kenny is a selective autophagy receptor that mediates the degradation of the IkappaB kinase (show CHUK Antibodies) complex. Selective autophagic degradation of the IkappaB kinase (show CHUK Antibodies) complex prevents constitutive activation of the immune deficiency pathway in response to commensal microbiota. We show that autophagy-deficient flies have a systemic innate immune response that promotes a hyperplasia phenotype in the midgut.
Porcine deltacoronavirus nsp5 (show SPECC1 Antibodies), the 3C-like protease, inhibits interferon-beta (show IFNB1 Antibodies) production through the cleavage of NEMO.
Nsp4 interfered with the NF-kappaB (show NFKB1 Antibodies) signaling pathway through the cleavage of IKBKG at the E349-S350 site, leading to the downregulation of IFN-beta (show IFNB1 Antibodies) production.
Foot-and-mouth disease virus 3C protease cleaves NEMO to impair innate immune signaling.
This gene encodes the regulatory subunit of the inhibitor of kappaB kinase (IKK) complex, which activates NF-kappaB resulting in activation of genes involved in inflammation, immunity, cell survival, and other pathways. Mutations in this gene result in incontinentia pigmenti, hypohidrotic ectodermal dysplasia, and several other types of immunodeficiencies. Multiple transcript variants encoding different isoforms have been found for this gene. A pseudogene highly similar to this locus is located in an adjacent region of the X chromosome.
I-kappa-B kinase subunit gamma
, IkB kinase gamma subunit
, NF-kappa-B essential modifier
, NF-kappa-B essential modulator
, NFkappaB essential modulator
, ikB kinase subunit gamma
, ikB kinase-associated protein 1
, incontinentia pigmenti
, inhibitor of nuclear factor kappa-B kinase subunit gamma
, inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
, I-kappa-B kinase gamma
, NF-kappa B essential modulator
, inhibitor of kappaB kinase gamma
, inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma, isoform 1
, inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma, isoform 2
, NF-kappa-B essential modulator-like